New Daily Persistent Headache in Children and Adolescents
First Online: 24 February 2010 DOI:
10.1007/s11910-010-0097-3 Cite this article as: Baron, E.P. & Rothner, A.D. Curr Neurol Neurosci Rep (2010) 10: 127. doi:10.1007/s11910-010-0097-3 Abstract
New daily persistent headache (NDPH) is a form of chronic daily headache (CDH) that may have features of both migraine and tension-type headache. In contrast with other types of CDH, NDPH is characterized by patients recalling the specific date their unremitting daily headache began. In comparison, chronic tension-type headache and chronic migraine are preceded by a gradually increasing frequency of headache. After several months, all three of these CDH forms often have a similar phenotype, making early history a key to diagnosing NDPH. Evaluations to exclude secondary causes are necessary but usually negative. NDPH is difficult to treat and requires a multimodal approach. Questions regarding NDPH remain unanswered. Additional prospective studies are necessary to further understand, characterize, diagnose, and treat NDPH.
Keywords New daily persistent headache Chronic daily headache Children Adolescents Chronic migraine Chronic tension-type headache References Papers of particular interest, published recently, have been highlighted as: • Of importance
Vanast WJ: New daily persistent headaches: definition of a benign syndrome. Headache 1986, 26:317–320.
Siberstein SD, Lipton RB, Solomon S, et al.: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994, 34:1–7.
Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.
• Kung E, Tepper SJ, Rapoport AM, et al.: New daily persistent headache in the paediatric population. Cephalalgia 2009, 29:17–22.
This article presents the most recent NDPH epidemiology data in a pediatric headache clinic population. It also proposes that NDPH be classified by abrupt onset of daily headache, given that its phenotype is similar to that of other forms of CDH.
Li D, Rozen TD: The clinical characteristics of new daily persistent headache. Cephalalgia 2002, 22:66–69.
Mack KJ: New daily persistent headache in children and adults. Curr Pain Headache Rep 2009, 13:47–51.
Abdelsalam HHM, Guo Y, Rothner AD: New daily persistent headache in children and adolescents [abstract]. Ann Neurol 2004, 56:S83–S131.
Scher AI, Stewart WF, Liberman J, et al.: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.
Castillo J, Munoz P, Guitera V, et al.: Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.
Winner P, Lewis DW, Rothner AD: Headache in Children and Adolescents, edn 2. New York: BC Decker Inc.; 2008.
Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006, 66:193–197.
Grande RB, Aaseth K, Lundqvist C, et al.: Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia 2009, 29:1149–1155.
Winner P, Gladstein J. Chronic daily headache in pediatric practice. Curr Opin Neurol 2002, 15:297–301.
Bigal ME, Lipton RB, Tepper SJ, et al.: Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 2004, 63:843–847.
Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002, 22:432–438.
Gladstein J, Holden EW: Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 1996, 36:349–351.
Koenig MA, Gladstein J, McCarter RJ, et al.: Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache 2002, 42:491–500.
Mack KJ: What incites new daily persistent headache in children? Pediatr Neurol 2004, 31:122–125.
Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575–581.
Santoni JR, Santoni-Williams CJ: Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med 1993, 32:530–532.
Stewart WF, Scher AI, Lipton RB: Stressful life events and risk of chronic daily headache: results from the frequent headache epidemiology study. Cephalalgia 2001, 21:278–280.
Diaz-Mitoma F, Vanast WJ, Tyrrell DL: Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987, 1:411–415.
Rozen TD: New daily persistent headache. Curr Pain Headache Rep 2003, 7:218–223.
Meineri P, Torre E, Rota E, et al.: New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci 2004, 25(Suppl 3):S281–S282.
Takase Y, Nakano M, Tatsumi C: Primary new daily persistent headache (NDPH): clinical characteristics of forty-three cases in Japan. Rinsho Shinkeigaku 2003, 43:533–538.
Pascual J: Other primary headaches. Neurol Clin 2009, 27:557–571.
Lewis DW, Ashwal S, Dahl G, et al.: Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002, 59:490–498.
Lewis DW, Dorbad D: The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache 2000, 40:629–632.
Schwedt TJ, Guo Y, Rothner AD: “Benign” imaging abnormalities in children and adolescents with headache. Headache 2006, 46:387–398.
• Mathew NT, Jaffri SF: A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 2009, 49:1466–1478.
This study reported similar efficacy between topiramate and botulinum toxin for CM prophylaxis.
Freitag FG, Diamond S, Diamond M, et al.: Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. Headache 2008, 48:201–209.
Chan VW, McCabe EJ, MacGregor DL: Botox treatment for migraine and chronic daily headache in adolescents. J Neurosci Nurs 2009, 41:235–243.
• Spears RC: Efficacy of botulinum toxin type A in new daily persistent headache. J Headache Pain 2008, 9:405–406.
This article provides a description of successful treatment of NDPH with botulinum toxin.
Rozen T, Swidan SZ: Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 2007, 47:1050–1055.
Rozen TD: Doxycycline for treatment resistant new daily persistent headache [abstract]. Headache 2008, 48:549.
Wintrich S, Rothner AD: Prognosis of new daily persistent headache in children and adolescents [abstract]. Submitted for presentation at the 62nd Annual Meeting of the American Academy of Neurology. Toronto, Canada; April 10–17, 2010.
© Springer Science+Business Media, LLC 2010